# agilon health (AGL) — Earnings

AGL · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/agl/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $1.04 |
| EPS estimate | $0.12 |
| EPS surprise | +790.41% |
| Revenue surprise | +2.90% |
| Revenue | $1.5B |
| Revenue estimate | $1.5B |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1831097/000162828026053355/agl-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/0d2964fb-aa05-f1b8-a19e-3617ca0769a1.html) |

Agilon Health reported Q2 2026 results on August 5, 2026. Earnings per share were $1.04, far above the $0.12 estimate, a surprise of 790.41%. Revenue was $1.5 billion, 2.90% above a consensus that also rounds to $1.5 billion. A year earlier, Q2 2025 showed a loss of $6.25 per share on revenue of $1.4 billion.

Q2 2026 was the second profitable quarter in a row, after $2.94 per share in Q1 2026, the high in the table. Before that, profits came only in first quarters; 14 of the 20 quarters shown were losses. Complete years were losses of $6.43 per share in 2022, $12.25 in 2023 and $15.25 in 2024. The table lists an unusually large loss of $287.50 per share for Q4 2025, against a $6.80 estimate, far out of line with every other quarter. Revenue grew from $458.6 million in Q3 2021 to between $1.4 billion and $1.6 billion a quarter since Q1 2024. Agilon beat the EPS estimate in 7 of the 20 quarters.

Agilon reported Q3 between October 28 and November 7 in each of the past five years. That points to late October or early November 2026 for the next report.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | $0.12 | $1.04 | 790.41% | $1.5B | $1.5B |
| Q1 2026 | May 6, 2026 | $1.04 | $2.94 | 182.56% | $1.4B | $1.4B |
| Q4 2025 | Feb 25, 2026 | −$6.80 | −$287.50 | -4129.68% | $1.5B | $1.6B |
| Q3 2025 | Nov 4, 2025 | −$3.73 | −$6.75 | -80.73% | $1.4B | $1.4B |
| Q2 2025 | Aug 4, 2025 | −$2.73 | −$6.25 | -128.94% | $1.5B | $1.4B |
| Q1 2025 | May 6, 2025 | −$0.07 | $0.73 | 1082.98% | $1.5B | $1.5B |
| Q4 2024 | Feb 25, 2025 | −$5.42 | −$6.50 | -19.85% | $1.5B | $1.5B |
| Q3 2024 | Nov 7, 2024 | −$2.46 | −$7.25 | -194.14% | $1.5B | $1.5B |
| Q2 2024 | Aug 6, 2024 | −$1.76 | −$1.75 | 0.43% | $1.5B | $1.5B |
| Q1 2024 | May 7, 2024 | −$0.32 | $0.25 | 178.99% | $1.6B | $1.6B |
| Q4 2023 | Feb 27, 2024 | −$6.92 | −$10.25 | -48.03% | $1.0B | $1.1B |
| Q3 2023 | Nov 2, 2023 | −$1.36 | −$2.00 | -47.23% | $1.1B | $1.2B |
| Q2 2023 | Aug 3, 2023 | −$0.46 | −$1.00 | -119.01% | $1.1B | $1.1B |
| Q1 2023 | May 9, 2023 | $0.88 | $1.00 | 14.29% | $1.1B | $1.1B |
| Q4 2022 | Mar 1, 2023 | −$2.43 | −$3.50 | -44.12% | $662.0M | $689.8M |
| Q3 2022 | Nov 3, 2022 | −$1.13 | −$1.75 | -55.31% | $662.2M | $695.0M |
| Q2 2022 | Aug 4, 2022 | −$0.42 | −$1.25 | -198.40% | $647.8M | $670.1M |
| Q1 2022 | May 5, 2022 | −$0.02 | $0.07 | 576.97% | $642.9M | $653.4M |
| Q4 2021 | Mar 3, 2022 | −$2.64 | −$3.50 | -32.72% | $452.9M | $462.9M |
| Q3 2021 | Oct 28, 2021 | −$2.13 | −$2.25 | -5.88% | $450.5M | $458.6M |

## Frequently Asked Questions

### When did agilon health (AGL) last report earnings?

agilon health last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did AGL beat earnings estimates?

Yes. agilon health reported EPS of $1.04 for Q2 2026 against a $0.12 estimate — a 790.41% beat.

### How much revenue did AGL report last quarter?

agilon health reported $1.5B in revenue for Q2 2026, against a consensus estimate of $1.5B.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).